HYOU1 Antikörper (AA 1-140)
-
- Target Alle HYOU1 Antikörper anzeigen
- HYOU1 (Hypoxia Up Regulated 1 (HYOU1))
-
Bindungsspezifität
- AA 1-140
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HYOU1 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- Antigen Affinity Purified
- Immunogen
- Recombinant Human Hypoxia up-regulated protein 1 protein (1-140AA)
- Isotyp
- IgG
- Top Product
- Discover our top product HYOU1 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- HYOU1 (Hypoxia Up Regulated 1 (HYOU1))
- Andere Bezeichnung
- HYOU1 (HYOU1 Produkte)
- Hintergrund
-
Background: Has a pivotal role in cytoprotective cellular mechanisms triggered by oxygen deprivation. May play a role as a molecular chaperone and participate in protein folding.
Aliases: 150 kDa oxygen regulated protein antibody, 150 kDa oxygen-regulated protein antibody, 170 kDa glucose regulated protein antibody, 170 kDa glucose-regulated protein antibody, DKFZp686N08236 antibody, FLJ94899 antibody, FLJ97572 antibody, glucose regulated protein 170 antibody, Grp 170 antibody, GRP-170 antibody, Grp170 antibody, HSP 12A antibody, HSP12A antibody, Hyou1 antibody, HYOU1_HUMAN antibody, Hypoxia up regulated 1 antibody, hypoxia up-regulated 1 precursor antibody, Hypoxia up-regulated protein 1 antibody, Hypoxia upregulated 1 antibody, Orp 150 antibody, ORP-150 antibody, Orp150 antibody, oxygen regulated protein (150kD) antibody
- UniProt
- Q9Y4L1
- Pathways
- ER-Nucleus Signaling, SARS-CoV-2 Protein Interaktom
-